{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:30:46Z","timestamp":1769556646829,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Program of Jilin University First Hospital Clinical Cultivation Fund","award":["LCPYJJ2017006"],"award-info":[{"award-number":["LCPYJJ2017006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>High serum uric acid (SUA) levels may provide protection against depression and anxiety through its defensive role in oxidative damage. The aim of this study was to test the hypothesis of the independent associations of lower SUA levels with depressive and anxiety symptoms among patients with epilepsy (PWE).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross-sectional study was performed among 320 PWE aged \u226518\u2009years old in Northeast China. The Neurological Disorders Depression Inventory for Epilepsy (NDDI-E; Chinese version) and the Generalized Anxiety Disorder-7 scale (GAD-7; Chinese version) were used as screening tools for depressive and anxiety symptoms for PWE. Serum uric acid levels were measured. The associations of SUA levels with depressive and anxiety symptoms were assessed by using binary logistic regression models, with adjustment for the related risk factors (<jats:italic>P<\/jats:italic>&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Lower SUA tertiles were significantly associated with higher C-NDDI-E and GAD-7 scores compared with the higher two tertiles (<jats:italic>p<\/jats:italic>=0.001, and <jats:italic>p<\/jats:italic>= 0.002). Patients with depressive symptoms exhibited significantly lower SUA levels compared to those without depressive symptoms (<jats:italic>p<\/jats:italic>&lt;\u20090.001). SUA levels of patients with anxiety symptoms were significantly lower than those of patients without anxiety symptoms (<jats:italic>p<\/jats:italic>&lt;\u20090.001). The first and second SUA tertiles were associated with depressive symptoms, with the third tertile group as the reference group, after adjusting for confounders (first tertile: OR = 4.694, 95% CI = 1.643~ 13.413, <jats:italic>P<\/jats:italic> = 0.004; second tertile: OR = 3.440, 95% CI = 1.278~9.256, <jats:italic>P<\/jats:italic> = 0.014). However, The first and second SUA tertiles were not associated with the risk of anxiety symptoms compared with the third tertile in the adjusted logistic regression model (First tertile: OR = 1.556, 95% CI = 0.699~3.464, <jats:italic>P<\/jats:italic> = 0.279; second tertile: OR = 1.265, 95% CI = 0.607~2.635, <jats:italic>P<\/jats:italic> = 0.530).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We found that lower SUA levels were independently associated with depressive symptoms but not with anxiety symptoms among PWE. Further well-designed prospective cohort studies are required to determine the causality of the associations and to further clarify the mechanisms of SUA in depressive symptoms.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-020-03019-8","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T16:03:46Z","timestamp":1610035426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A cross-sectional study on the association of serum uric acid levels with depressive and anxiety symptoms in people with epilepsy"],"prefix":"10.1186","volume":"21","author":[{"given":"Rui","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengmeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaojia","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"issue":"10172","key":"3019_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","volume":"393","author":"RD Thijs","year":"2019","unstructured":"Thijs RD, Surges R, O\u2019Brien TJ, Sander JW. Epilepsy in adults. Lancet. 2019;393(10172):689\u2013701.","journal-title":"Lancet"},{"issue":"7","key":"3019_CR2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S1474-4422(19)30068-7","volume":"18","author":"MS Ouriques","year":"2019","unstructured":"Ouriques MS, Sacks C, Hacke W, Brainin M, de Assis FF, Marques PO, Lavados GP, Marinho MF, Hoppe WA, Vaca MD, et al. Priorities to reduce the burden of stroke in Latin American countries. Lancet Neurol. 2019;18(7):674\u201383.","journal-title":"Lancet Neurol"},{"issue":"6","key":"3019_CR3","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/epi.13769","volume":"58","author":"AJ Scott","year":"2017","unstructured":"Scott AJ, Sharpe L, Hunt C, Gandy M. Anxiety and depressive disorders in people with epilepsy: a meta-analysis. Epilepsia. 2017;58(6):973\u201382.","journal-title":"Epilepsia"},{"issue":"2","key":"3019_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/0883073815587942","volume":"31","author":"KL Kwong","year":"2016","unstructured":"Kwong KL, Lam D, Tsui S, Ngan M, Tsang B, Lai TS, Lam SM. Anxiety and depression in adolescents with epilepsy. J Child Neurol. 2016;31(2):203\u201310.","journal-title":"J Child Neurol"},{"issue":"3","key":"3019_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3988\/jcn.2014.10.3.175","volume":"10","author":"OY Kwon","year":"2014","unstructured":"Kwon OY, Park SP. Depression and anxiety in people with epilepsy. J Clin Neurol. 2014;10(3):175\u201388.","journal-title":"J Clin Neurol"},{"issue":"6","key":"3019_CR6","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/j.1528-1167.2012.03500.x","volume":"53","author":"D Rai","year":"2012","unstructured":"Rai D, Kerr MP, McManus S, Jordanova V, Lewis G, Brugha TS. Epilepsy and psychiatric comorbidity: a nationally representative population-based study. Epilepsia. 2012;53(6):1095\u2013103.","journal-title":"Epilepsia"},{"issue":"3","key":"3019_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1590\/S0004-282X2013000300011","volume":"71","author":"KD Valente","year":"2013","unstructured":"Valente KD, Busatto FG. Depression and temporal lobe epilepsy represent an epiphenomenon sharing similar neural networks: clinical and brain structural evidences. Arq Neuropsiquiatr. 2013;71(3):183\u201390.","journal-title":"Arq Neuropsiquiatr"},{"key":"3019_CR8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.yebeh.2018.06.019","volume":"85","author":"K Yeni","year":"2018","unstructured":"Yeni K, Tulek Z, Simsek OF, Bebek N. Relationships between knowledge, attitudes, stigma, anxiety and depression, and quality of life in epilepsy: a structural equation modeling. Epilepsy Behav. 2018;85:212\u20137.","journal-title":"Epilepsy Behav"},{"issue":"Suppl 1","key":"3019_CR9","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.yebeh.2008.04.005","volume":"13","author":"JJ Barry","year":"2008","unstructured":"Barry JJ, Ettinger AB, Friel P, Gilliam FG, Harden CL, Hermann B, Kanner AM, Caplan R, Plioplys S, Salpekar J, et al. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav. 2008;13(Suppl 1):S1\u2013S29.","journal-title":"Epilepsy Behav"},{"issue":"6","key":"3019_CR10","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/ane.13085","volume":"139","author":"FM Snoeijen-Schouwenaars","year":"2019","unstructured":"Snoeijen-Schouwenaars FM, van Ool JS, Tan IY, Aldenkamp AP, Schelhaas HJ, Hendriksen J. Mood, anxiety, and perceived quality of life in adults with epilepsy and intellectual disability. Acta Neurol Scand. 2019;139(6):519\u201325.","journal-title":"Acta Neurol Scand"},{"key":"3019_CR11","doi-asserted-by":"publisher","first-page":"2571368","DOI":"10.1155\/2019\/2571368","volume":"2019","author":"D Plevin","year":"2019","unstructured":"Plevin D, Smith N. Assessment and Management of Depression and Anxiety in children and adolescents with epilepsy. Behav Neurol. 2019;2019:2571368.","journal-title":"Behav Neurol"},{"issue":"11","key":"3019_CR12","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","volume":"78","author":"BN Ames","year":"1981","unstructured":"Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A. 1981;78(11):6858\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3019_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jad.2017.04.042","volume":"219","author":"LR Steenkamp","year":"2017","unstructured":"Steenkamp LR, Hough CM, Reus VI, Jain FA, Epel ES, James SJ, Morford AE, Mellon SH, Wolkowitz OM, Lindqvist D. Severity of anxiety- but not depression- is associated with oxidative stress in major depressive disorder. J Affect Disord. 2017;219:193\u2013200.","journal-title":"J Affect Disord"},{"key":"3019_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jad.2018.05.079","volume":"238","author":"M Shafiee","year":"2018","unstructured":"Shafiee M, Ahmadnezhad M, Tayefi M, Arekhi S, Vatanparast H, Esmaeili H, Moohebati M, Ferns GA, Mokhber N, Arefhosseini SR, et al. Depression and anxiety symptoms are associated with prooxidant-antioxidant balance: a population-based study. J Affect Disord. 2018;238:491\u20138.","journal-title":"J Affect Disord"},{"issue":"1\u20132","key":"3019_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.clinbiochem.2011.10.010","volume":"45","author":"S Wen","year":"2012","unstructured":"Wen S, Cheng M, Wang H, Yue J, Wang H, Li G, Zheng L, Zhong Z, Peng F. Serum uric acid levels and the clinical characteristics of depression. Clin Biochem. 2012;45(1\u20132):49\u201353.","journal-title":"Clin Biochem"},{"key":"3019_CR16","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jad.2017.09.003","volume":"225","author":"CN Black","year":"2018","unstructured":"Black CN, Bot M, Scheffer PG, Snieder H, Penninx B. Uric acid in major depressive and anxiety disorders. J Affect Disord. 2018;225:684\u201390.","journal-title":"J Affect Disord"},{"key":"3019_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fpsyt.2020.00052","volume":"11","author":"G Li","year":"2020","unstructured":"Li G, Miao J, Sun W, Song X, Lan Y, Zhao X, Qiu X, Zhang C, Zhu Z, Zhu S. Lower serum uric acid is associated with post-stroke depression at discharge. Front Psychiatry. 2020;11:52.","journal-title":"Front Psychiatry"},{"key":"3019_CR18","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jad.2014.12.031","volume":"174","author":"R Tao","year":"2015","unstructured":"Tao R, Li H. High serum uric acid level in adolescent depressive patients. J Affect Disord. 2015;174:464\u20136.","journal-title":"J Affect Disord"},{"issue":"1","key":"3019_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12640-018-9930-2","volume":"35","author":"D Wang","year":"2019","unstructured":"Wang D, Hu B, Dai Y, Sun J, Liu Z, Feng Y, Cheng F, Zhang X. Serum uric acid is highly associated with epilepsy secondary to cerebral infarction. Neurotox Res. 2019;35(1):63\u201370.","journal-title":"Neurotox Res"},{"issue":"3","key":"3019_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0920-1211(91)90070-V","volume":"8","author":"HA Ring","year":"1991","unstructured":"Ring HA, Heller AJ, Marshall WJ, Johnson AL, Reynolds EH. Plasma uric acid in patients receiving anticonvulsant monotherapy. Epilepsy Res. 1991;8(3):241\u20134.","journal-title":"Epilepsy Res"},{"issue":"6","key":"3019_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/ane.13016","volume":"138","author":"HJ Wang","year":"2018","unstructured":"Wang HJ, Tan G, Deng Y, He J, He YJ, Zhou D, Liu L. Prevalence and risk factors of depression and anxiety among patients with convulsive epilepsy in rural West China. Acta Neurol Scand. 2018;138(6):541\u20137.","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"3019_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S1474-4422(06)70415-X","volume":"5","author":"FG Gilliam","year":"2006","unstructured":"Gilliam FG, Barry JJ, Hermann BP, Meador KJ, Vahle V, Kanner AM. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol. 2006;5(5):399\u2013405.","journal-title":"Lancet Neurol"},{"issue":"10","key":"3019_CR23","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137.","journal-title":"Arch Intern Med"},{"key":"3019_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.yebeh.2015.03.012","volume":"47","author":"X Tong","year":"2015","unstructured":"Tong X, An D, Lan L, Zhou X, Zhang Q, Xiao F, Park SP, Kanemoto K, Kanner AM, Zhou D. Validation of the Chinese version of the neurological disorders depression inventory for epilepsy (C-NDDI-E) in West China. Epilepsy Behav. 2015;47:6\u201310.","journal-title":"Epilepsy Behav"},{"key":"3019_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.eplepsyres.2015.11.019","volume":"120","author":"X Tong","year":"2016","unstructured":"Tong X, An D, McGonigal A, Park SP, Zhou D. Validation of the generalized anxiety Disorder-7 (GAD-7) among Chinese people with epilepsy. Epilepsy Res. 2016;120:31\u20136.","journal-title":"Epilepsy Res"},{"issue":"3","key":"3019_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.arcmed.2006.10.010","volume":"38","author":"M Togha","year":"2007","unstructured":"Togha M, Akhondzadeh S, Motamedi M, Ahmadi B, Razeghi S. Allopurinol as adjunctive therapy in intractable epilepsy: a double-blind and placebo-controlled trial. Arch Med Res. 2007;38(3):313\u20136.","journal-title":"Arch Med Res"},{"key":"3019_CR27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.seizure.2019.02.014","volume":"66","author":"Q Li","year":"2019","unstructured":"Li Q, Chen D, Zhu LN, Wang HJ, Xu D, Tan G, Zhang Y, Liu L. Depression in people with epilepsy in West China: status, risk factors and treatment gap. Seizure. 2019;66:86\u201392.","journal-title":"Seizure"},{"issue":"10","key":"3019_CR28","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1080\/13548506.2019.1622748","volume":"24","author":"Y Li","year":"2019","unstructured":"Li Y, Zhao L, Yu D, Ding G. Associations between serum uric acid and depression among middle-aged and elderly participants in China. Psychol Health Med. 2019;24(10):1277\u201386.","journal-title":"Psychol Health Med"},{"key":"3019_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/NDT.S149712","volume":"14","author":"J Gao","year":"2018","unstructured":"Gao J, Xu W, Han K, Zhu L, Gao L, Shang X. Changes of serum uric acid and total bilirubin in elderly patients with major postischemic stroke depression. Neuropsychiatr Dis Treat. 2018;14:83\u201393.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"10","key":"3019_CR30","first-page":"e138904","volume":"10","author":"T Liu","year":"2015","unstructured":"Liu T, Zhong S, Liao X, Chen J, He T, Lai S, Jia Y. A meta-analysis of oxidative stress markers in depression. PLoS One. 2015;10(10):e138904.","journal-title":"PLoS One"},{"issue":"12","key":"3019_CR31","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.4088\/JCP.14r09179","volume":"76","author":"S Jimenez-Fernandez","year":"2015","unstructured":"Jimenez-Fernandez S, Gurpegui M, Diaz-Atienza F, Perez-Costillas L, Gerstenberg M, Correll CU. Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment: results from a meta-analysis. J Clin Psychiatry. 2015;76(12):1658\u201367.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"3019_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/0097840X.1984.9934958","volume":"10","author":"RJ Biersner","year":"1984","unstructured":"Biersner RJ, McHugh WB, Rahe RH. Biochemical and mood responses predictive of stressful diving performance. J Hum Stress. 1984;10(1):43\u20139.","journal-title":"J Hum Stress"},{"issue":"7","key":"3019_CR33","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1001\/jama.1968.03150070038006","volume":"206","author":"SV Kasl","year":"1968","unstructured":"Kasl SV, Cobb S, Brooks GW. Changes in serum uric acid and cholesterol levels in men undergoing job loss. JAMA. 1968;206(7):1500\u20137.","journal-title":"JAMA"},{"key":"3019_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.yebeh.2016.06.038","volume":"62","author":"HJ Moon","year":"2016","unstructured":"Moon HJ, Seo JG, Park SP. Perceived stress and its predictors in people with epilepsy. Epilepsy Behav. 2016;62:47\u201352.","journal-title":"Epilepsy Behav"},{"issue":"32","key":"3019_CR35","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.2174\/138161205774913255","volume":"11","author":"GK Glantzounis","year":"2005","unstructured":"Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr Pharm Des. 2005;11(32):4145\u201351.","journal-title":"Curr Pharm Des"},{"issue":"6","key":"3019_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.numecd.2007.02.011","volume":"17","author":"P Strazzullo","year":"2007","unstructured":"Strazzullo P, Puig JG. Uric acid and oxidative stress: relative impact on cardiovascular risk? Nutr Metab Cardiovasc Dis. 2007;17(6):409\u201314.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"3019_CR37","first-page":"567","volume":"22","author":"S Dasgupta","year":"2013","unstructured":"Dasgupta S, Dasgupta A, Mukhopadhayay T, Bhattacharya S, Swaika B, Banarjee U, Chakrabarty P. Serum uric acid: an early indicator of oxidative stress in beta thalassemia population. Mymensingh Med J. 2013;22(3):567\u201373.","journal-title":"Mymensingh Med J"},{"issue":"1","key":"3019_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1124\/jpet.116.237503","volume":"360","author":"S Salim","year":"2017","unstructured":"Salim S. Oxidative stress and the central nervous system. J Pharmacol Exp Ther. 2017;360(1):201\u20135.","journal-title":"J Pharmacol Exp Ther"},{"key":"3019_CR39","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.psyneuen.2014.09.025","volume":"51","author":"CN Black","year":"2015","unstructured":"Black CN, Bot M, Scheffer PG, Cuijpers P, Penninx BW. Is depression associated with increased oxidative stress? A systematic review and meta-analysis. Psychoneuroendocrino. 2015;51:164\u201375.","journal-title":"Psychoneuroendocrino"},{"issue":"5","key":"3019_CR40","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/14737175.2018.1465410","volume":"18","author":"U Geronzi","year":"2018","unstructured":"Geronzi U, Lotti F, Grosso S. Oxidative stress in epilepsy. Expert Rev Neurother. 2018;18(5):427\u201334.","journal-title":"Expert Rev Neurother"},{"issue":"5","key":"3019_CR41","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/mp.2012.33","volume":"18","author":"S Moylan","year":"2013","unstructured":"Moylan S, Maes M, Wray NR, Berk M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry. 2013;18(5):595\u2013606.","journal-title":"Mol Psychiatry"},{"issue":"12","key":"3019_CR42","first-page":"C4","volume":"8","author":"A Bajpai","year":"2014","unstructured":"Bajpai A, Verma AK, Srivastava M, Srivastava R. Oxidative stress and major depression. J Clin Diagn Res. 2014;8(12):C4\u20137.","journal-title":"J Clin Diagn Res"},{"issue":"3","key":"3019_CR43","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.pnpbp.2010.05.004","volume":"35","author":"M Maes","year":"2011","unstructured":"Maes M, Galecki P, Chang YS, Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness. Prog Neuro-Psychopharmacol Biol Psychiatry. 2011;35(3):676\u201392.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"3019_CR44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.pnpbp.2014.10.016","volume":"57","author":"R Ortiz","year":"2015","unstructured":"Ortiz R, Ulrich H, Zarate CJ, Machado-Vieira R. Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics. Prog Neuro-Psychopharmacol Biol Psychiatry. 2015;57:117\u201331.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"3019_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.psyneuen.2016.04.017","volume":"70","author":"T Ali-Sisto","year":"2016","unstructured":"Ali-Sisto T, Tolmunen T, Toffol E, Viinamaki H, Mantyselka P, Valkonen-Korhonen M, Honkalampi K, Ruusunen A, Velagapudi V, Lehto SM. Purine metabolism is dysregulated in patients with major depressive disorder. Psychoneuroendocrino. 2016;70:25\u201332.","journal-title":"Psychoneuroendocrino"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-020-03019-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-020-03019-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-020-03019-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T23:09:25Z","timestamp":1610060965000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-020-03019-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3019"],"URL":"https:\/\/doi.org\/10.1186\/s12888-020-03019-8","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"29 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This cross-sectional study was carried out in the Department of Neurology, First Hospital of Jilin University. The Ethics Committee of the First Hospital of Jilin University (approval No: 2017\u2013326) approved the study, and written informed consent was obtained from all participants or their legal representatives.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent to publish the paper was obtained from all authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}